Novel Biomarkers for Diagnosing and Managing Heart Failure


Price: $0.00

Register for this webinar and hear about new developments in the fast-paced world of heart failure biomarkers. An expert cardiologist will review the evidence linking BNP-guided therapy to better patient outcomes, discuss the emerging roles assays such as MR-proANP, Galectin 3, hs-cTn and ST2 may play in the diagnosis, risk stratification and management of heart failure patients, and discuss what the future may hold in terms of using these markers to improve patient care.